All Stories

  1. Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats

    Article • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals

    Ms Jennifer L Hoover

  2. PK/PD of PDF inhibitor GSK1322322 in rodents

    Article • Antimicrobial Agents and Chemotherapy, October 2015, ASM Journals

    Ms Jennifer L Hoover

  3. Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

    Article • Bioorganic & Medicinal Chemistry Letters, October 2013, Elsevier

    Ms Jennifer L Hoover

  4. Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerases

    Article • Bioorganic & Medicinal Chemistry Letters, December 2011, Elsevier

    Ms Jennifer L Hoover

  5. Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases

    Article • Bioorganic & Medicinal Chemistry Letters, December 2011, Elsevier

    Ms Jennifer L Hoover

  6. Antibacterial Drug Discovery in the Age of Resistance

    Article • Microbe Magazine, January 2010, ASM Journals

    Ms Jennifer L Hoover

  7. Use of the Surgical Wound Infection Model To Determine the Efficacious Dosing Regimen of Retapamulin, a Novel Topical Antibiotic

    Article • Antimicrobial Agents and Chemotherapy, October 2006, ASM Journals

    Ms Jennifer L Hoover

  8. Comparative Bacteriological Efficacy of Pharmacokinetically Enhanced Amoxicillin-Clavulanate against Streptococcus pneumoniae with Elevated Amoxicillin MICs and Haemophilus influenzae

    Article • Antimicrobial Agents and Chemotherapy, March 2005, ASM Journals

    Ms Jennifer L Hoover

  9. Comparative efficacy of gemifloxacin in experimental models of pyelonephritis and wound infection

    Article • Journal of Antimicrobial Chemotherapy, April 2000, Oxford University Press (OUP)

    Ms Jennifer L Hoover

  10. Comparative in vivo activity of gemifloxacin in a rat model of respiratory tract infection

    Article • Journal of Antimicrobial Chemotherapy, April 2000, Oxford University Press (OUP)

    Ms Jennifer L Hoover

  11. Selective immunomodulatory activity of SK&F 106615, a macrophage-targeting antiarthritic compound, on antibody and cellular responses in rats and mice

    Article • Immunopharmacology, August 1997, Elsevier

    Ms Jennifer L Hoover